PT-141, also known as Bremelanotide, is an FDA-approved peptide therapy specifically designed to improve sexual dysfunction in premenopausal women by targeting the nervous system rather than the cardiovascular system. This innovative treatment enhances sexual arousal and performance, offering a non-invasive option with rapid and long-lasting effects. PT-141 is administered through injections, ensuring efficient absorption and effectiveness in enhancing sexual function.